Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level Recall of One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, Due to Potential Metal Contamination
Recall from a federal regulator
Headline as published by U.S. Food and Drug Administration (MedWatch) on Nov 20, 2026; collected by the wire Nov 20, 2026, 3:30 PM ET.
November 16, 2026— Breckenridge Pharmaceutical, Inc. (Breckenridge) is voluntarily recalling to the consumer level one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination.
Coverage
Topics
- Recalls and safety alertsMatched on
Recall
Explore the named firms, organizations and MDL dockets above. Sources and method